XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Net Loss Per Common Share (Tables)
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic
The following table provides a reconciliation of net loss to net loss available to common stockholders and calculation of basic net loss per common share for each of the three months ended March 31, 2022 and 2021 (amounts in thousands, except share and per share amounts):
 Three Months Ended March 31,
 20222021
Net loss$(10,489)$(8,382)
Adjustments to reconcile to net loss available to common stockholders
Accumulated dividend on Series B Preferred Stock1,586 1,006 
Accretion of increasing-rate dividend feature— 462 
Total adjustments1,586 1,468 
Net loss available to common stockholders$(12,075)$(9,850)
Weighted average common shares outstanding111,615,839 109,401,383 
Basic net loss per common share$(0.11)$(0.09)
Schedule of Earnings Per Share, Diluted
The following table sets forth the computation of diluted net loss per common share (in thousands, except share and per share amounts):
 Three Months Ended March 31,
 20222021
Net loss available to common stockholders$(12,075)$(9,850)
Adjustments:
Dividends on Series B Convertible Preferred Stock1,586 1,468 
Less: antidilutive adjustments(1,586)(1,468)
Total adjustments— — 
Numerator$(12,075)$(9,850)
Weighted average shares outstanding111,615,839 109,401,383 
Adjustments
Potential common shares29,459,846 30,470,089 
Less: antidilutive potential common shares (a)(29,459,846)(30,470,089)
Total adjustments— — 
Weighted average shares outstanding adjusted for potential common shares111,615,839 109,401,383 
Diluted net loss per common share$(0.11)$(0.09)
(a) Weighted average common shares outstanding for the calculation of diluted net loss per common share does not include the following adjustments for potential common shares below because their effects were determined to be antidilutive for the periods presented.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Three Months Ended March 31,
20222021
Series B Convertible Preferred Stock27,850,916 26,497,570 
Restricted stock awards597,805 1,629,273 
Restricted stock unit awards822,642 1,349,898 
Outstanding stock options188,483 964,640 
Performance stock unit awards— 28,708 
Potential common shares29,459,846 30,470,089